Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;86:730-740

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fananapazir, L.
Right arrow Articles by McAreavey, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fananapazir, L.
Right arrow Articles by McAreavey, D.

Circulation, Vol 86, 730-740, Copyright © 1992 by American Heart Association


ARTICLES

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

L Fananapazir, AC Chang, SE Epstein and D McAreavey
Electrophysiology Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

BACKGROUND. Patients with hypertrophic cardiomyopathy (HCM) frequently have arrhythmias and hemodynamic abnormalities and are prone to sudden death and syncope. An important need exists for improved risk stratification and definition of appropriate investigation and therapy. METHODS AND RESULTS. The relation of 31 clinical, Holter, cardiac catheterization, and electrophysiological (EP) variables to subsequent cardiac events in 230 HCM patients was examined by multivariate analysis. Studies were for cardiac arrest (n = 32), syncope (n = 80), presyncope (n = 52), ventricular tachycardia (VT) on Holter (n = 36), a strong family history of sudden death (n = 9), and palpitations (n = 21). Nonsustained VT on Holter was present in 115 patients (50%). Sustained ventricular arrhythmia was induced in 82 patients (36%). Seventeen cardiac events (eight sudden deaths, one cardiac arrest, and eight syncope with defibrillator discharges) occurred during a follow- up of 28 +/- 19 months. The 1-year and 5-year event-free rates were 99% and 79%, respectively. Two variables were significant independent predictors of subsequent events: sustained ventricular arrhythmia induced at EP study (beta, 3.5; p = 0.002) and a history of cardiac arrest or syncope (beta, 2.9; p less than 0.05). Only two of 66 patients without symptoms of impaired consciousness had a cardiac event (3-year event-free rate, 97%). In contrast, nonsustained VT on Holter was associated with a worse prognosis only in patients with symptoms of impaired consciousness: 11 of 79 symptomatic patients with VT on Holter (14%) had events versus only four of 85 symptomatic patients without VT on Holter (5%) (p = 0.057). Notably, none of 51 patients without symptoms of impaired consciousness in whom VT was not induced at EP study had a cardiac event. CONCLUSIONS. In HCM, VT on Holter is of benign prognostic significance in the absence of symptoms of impaired consciousness and inducible VT, and sustained VT induced at EP study, especially when associated with cardiac arrest or syncope, identifies a subgroup at high risk for subsequent cardiac events.


This article has been cited by other articles:


Home page
EuropaceHome page
M. Haghjoo, S. Mohammadzadeh, M. Taherpour, B. Faghfurian, A. F. Fazelifar, A. Alizadeh, M. A. Rad, and M. A. Sadr-Ameli
ST-segment depression as a risk factor in hypertrophic cardiomyopathy
Europace, May 1, 2009; 11(5): 643 - 649.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. C. Saumarez, M. Pytkowski, M. Sterlinski, J. P. Bourke, J. R. Clague, S. M. Cobbe, D. T. Connelly, M. J. Griffith, P. P. McKeown, K. McLeod, et al.
Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy
Eur. Heart J., July 1, 2008; 29(13): 1653 - 1661.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. A. Stephenson and C. I. Berul
Electrophysiological Interventions for Inherited Arrhythmia Syndromes
Circulation, August 28, 2007; 116(9): 1062 - 1080.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
EuropaceHome page
F. Enseleit and F. Duru
Long-term continuous external electrocardiographic recording: a review.
Europace, April 1, 2006; 8(4): 255 - 266.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. W. Nugent, P. E.F. Daubeney, P. Chondros, J. B. Carlin, S. D. Colan, M. Cheung, A. M. Davis, C.W. Chow, R. G. Weintraub, and for the National Australian Childhood Cardiomyopat
Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study
Circulation, August 30, 2005; 112(9): 1332 - 1338.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Hiasa, M. Hamada, H. Saeki, A. Ogimoto, T. Ohtsuka, Y. Hara, and Y. Shigematsu
Cardiac Sympathetic Nerve Activity Can Detect Congestive Heart Failure Sensitively in Patients With Hypertrophic Cardiomyopathy
Chest, September 1, 2004; 126(3): 679 - 686.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. P Frenneaux
Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy
Heart, May 1, 2004; 90(5): 570 - 575.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991.
[Full Text] [PDF]


Home page
CirculationHome page
R. C. Saumarez, L. Chojnowska, R. Derksen, M. Pytkowski, M. Sterlinski, C. L.-H. Huang, N. Sadoul, R. N.W. Hauer, W. Ruzyllo, and A. A. Grace
Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation
Circulation, May 27, 2003; 107(20): 2595 - 2600.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. J. Marian
On predictors of sudden cardiac death in hypertrophic cardiomyopathy
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 994 - 996.
[Full Text] [PDF]


Home page
HeartHome page
J. M Morgan
PATIENTS WITH VENTRICULAR ARRHYTHMIAS: WHO SHOULD BE REFERRED TO AN ELECTROPHYSIOLOGIST?
Heart, December 1, 2002; 88(5): 544 - 550.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M.J. Janse and J.M.T. De Bakker
Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable card ioverter-defibrillators
Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L15 - L20.
[Abstract] [PDF]


Home page
Eur Heart JHome page
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450.
[PDF]


Home page
Cardiovasc ResHome page
R.C. Saumarez and A.A. Grace
Paced ventricular electrogram fractionation and sudden death in hypertrophic cardiomyopathy and other non-coronary heart diseases
Cardiovasc Res, July 1, 2000; 47(1): 11 - 22.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S.-T. Li, C. J. Tack, L. Fananapazir, and D. S. Goldstein
Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1867 - 1873.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. L. Atiga, L. Fananapazir, D. McAreavey, H. Calkins, and R. D. Berger
Temporal Repolarization Lability in Hypertrophic Cardiomyopathy Caused by {beta}-Myosin Heavy-Chain Gene Mutations
Circulation, March 21, 2000; 101(11): 1237 - 1242.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. L. Gil, F. Arribas, and F. G. Cosio
Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy
Europace, January 1, 2000; 2(4): 327 - 332.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al.
ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
P. J. Zimetbaum and M. E. Josephson
The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice
Ann Intern Med, May 18, 1999; 130(10): 848 - 856.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. Fananapazir
Advances in Molecular Genetics and Management of Hypertrophic Cardiomyopathy
JAMA, May 12, 1999; 281(18): 1746 - 1752.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Takagi, T. Yamakado, and T. Nakano
Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 206 - 211.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. Hirayama, K. Marumoto, H. Okayama, T. Iwata, and M. Suzuki
Paroxysmal Atrial Fibrillation as a Cause of Potentially Lethal Ventricular Arrhythmia with Myocardial Ischemia in Hypertrophic Cardiomyopathy: A Case Report
Angiology, August 1, 1998; 49(8): 653 - 657.
[Abstract] [PDF]


Home page
CirculationHome page
E. Lazzeroni, E. Picano, L. Morozzi, A. R. Maurizio, G. Palma, R. Ceriati, E. Iori, and A. Barilli
Dipyridamole-Induced Ischemia as a Prognostic Marker of Future Adverse Cardiac Events in Adult Patients With Hypertrophic Cardiomyopathy
Circulation, December 16, 1997; 96(12): 4268 - 4272.
[Abstract] [Full Text]


Home page
NEJMHome page
J. J. Allan, R. Paz, P. A. Tunick, and I. Kronzon
Ethanol and Hypertrophic Cardiomyopathy
N. Engl. J. Med., March 20, 1997; 336(12): 878 - 878.
[Full Text]


Home page
NEJMHome page
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron
The Management of Hypertrophic Cardiomyopathy
N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. A. Theodoro, G. K. Danielson, R. H. Feldt, and B. J. Anderson
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY IN PEDIATRIC PATIENTS: RESULTS OF SURGICAL TREATMENT
J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1589 - 1599.
[Abstract] [Full Text]


Home page
CirculationHome page
C. R. Cannan, G. S. Reeder, K. R. Bailey, L. J. Melton III, and B. J. Gersh
Natural History of Hypertrophic Cardiomyopathy : A Population-Based Study, 1976 Through 1990
Circulation, November 1, 1995; 92(9): 2488 - 2495.
[Abstract] [Full Text]


Home page
CirculationHome page
E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams
Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment
Circulation, October 1, 1995; 92(7): 1680 - 1692.
[Full Text]


Home page
CirculationHome page
R. C. Saumarez, A. K. B. Slade, A. A. Grace, N. Sadoul, A. J. Camm, and W. J. McKenna
The Significance of Paced Electrogram Fractionation in Hypertrophic Cardiomyopathy : A Prospective Study
Circulation, June 1, 1995; 91(11): 2762 - 2768.
[Abstract] [Full Text]


Home page
BMJHome page
D C Lefroy
Grand Rounds - Hammersmith Hospital: Cardiac arrest and hypertrophic cardiomyopathy
BMJ, November 12, 1994; 309(6964): 1277 - 1279.
[Full Text]